Status:

UNKNOWN

Mueller Polarimetric Colposcopy for High-performance Detection of Cervical Changes During Pregnancy

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Pregnancy Related

Premature Birth

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Mueller polarimetric colposcopy appears to be a powerful tool for evaluating cervical microstructure modification during pregnancy. Some polarimetric parameters of the uterine cervix can be correlated...

Detailed Description

Interventional research protocol involving the human person relating to a medical device. This is a prospective, not randomized, monocentric study. Prematurity accounts for around 11% of births worldw...

Eligibility Criteria

Inclusion

  • Major patient.
  • Single pregnancy.
  • Baseline ≥ 20 amenorrhea week and \<37 amenorrhea week.
  • Dating obtained by ultrasound of the 1st trimester.
  • Written and informed consent.
  • Group 1 (low risk):
  • Asymptomatic patient benefiting from usual follow-up in the maternity hospital.
  • \> Group 2 (high risk): Symptomatic patient with cervical changes objectified by endovaginal ultrasound of the cervix with an effective length of \<20mm.
  • Asymptomatic patient with a history of premature delivery or late miscarriage and cervical changes objectified by endovaginal ultrasound of the cervix with an effective length of \<20mm."

Exclusion

  • Known uterine malformation or suspected uterine malformation.
  • Pregnancy circled.
  • Premature rupture of membranes.
  • Suspicion of chorioamnionitis.
  • Abundant active bleeding hindering the visualization of the cervix.
  • History of conization.
  • Imminent childbirth.
  • Known medical indication at a birth \<37 amenorrhea week (severe pre-eclampsia, severe intrauterine growth retardation, hemorrhagic placenta previa, fetal malformations,….).
  • Examination of the cervix under speculum not possible.
  • Lack of social coverage (AME).
  • Limited understanding.
  • Participation in another intervention research.
  • \> Group1 (Low risk):
  • History of spontaneous premature labor.
  • History of late miscarriage.
  • History of premature rupture of membranes."

Key Trial Info

Start Date :

December 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2024

Estimated Enrollment :

683 Patients enrolled

Trial Details

Trial ID

NCT04661553

Start Date

December 1 2020

End Date

May 1 2024

Last Update

December 10 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.